Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XFOR

X4 Pharmaceuticals Inc

Jun 12 • 10:47AM ET

4.01

+0.13 3.48 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BMRN INCY KRYS KYMR NUVL RYTM VKTX AXSM MDGL NBIX

| Held by: VTI VXF AVSC PRFZ BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.54	Insider Own	19.50%	Shs Outstand	94.32M	Perf Week	4.83%
Market Cap	378.69M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-0.09%	Shs Float	75.92M	Perf Month	-5.08%
Enterprise Value	222.22M	PEG	-	EPS next Q	-0.18	Inst Own	82.79%	Short Float	4.44%	Perf Quarter	8.81%
Income	-99.72M	P/S	42.03	EPS this Y	60.96%	Inst Trans	2.84%	Short Ratio	8.56	Perf Half Y	3.21%
Sales	9.01M	P/B	2.25	EPS next Y	-9.25%	ROA	-49.82%	Short Interest	3.37M	Perf YTD	0.37%
Book/sh	1.79	P/C	1.62	EPS next 5Y	27.70%	ROE	-104.21%	52W High	4.83 -16.87%	Perf Year	31.64%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	65.48% 54.19%	ROIC	-40.71%	52W Low	1.35 197.41%	Perf 3Y	-94.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 63.56%	Gross Margin	79.04%	Volatility	6.94% 6.12%	Perf 5Y	-98.47%
Dividend TTM	-	EV/Sales	24.66	EPS Y/Y TTM	-300.04%	Oper. Margin	-1084.38%	ATR (14)	0.23	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.98	Sales Y/Y TTM	-71.26%	Profit Margin	-1106.30%	RSI (14)	50.73	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.18	EPS Q/Q	-490.02%	SMA20	1.99%	Beta	0.39	Target Price	11.75
Payout	-	Debt/Eq	0.46	Sales Q/Q	-90.60%	SMA50	-1.85%	Rel Volume	1.71	Prev Close	3.88
Employees	45	LT Debt/Eq	0.45	Earnings	May 06 BMO	SMA200	6.78%	Avg Volume	393.72K	Price	4.01
IPO	Nov 16, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.00% -22.84%	Trades		Volume	160,190	Change	3.48%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)